How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research bioMerieux Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
253 clearance records and 572 recall records in the covered releases, across 1 source company names and 88 product codes. Dated history runs from Feb 9, 1983 to Nov 4, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 1 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 1 |
| July 2026 | 1 | 1 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 1 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| VITEK MS PRIMEK212461 · QBN | bioMerieux, Inc. | 510(k) | Mar 15, 2022FDA decision date |
| VIDAS CMV IgM, 30 tests, REF 30205-01, IVD, Rx.Z-0742-2022 · LKQ | bioMerieux, Inc. | Recall | Mar 14, 2022FDA classification date |
| VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS FluconazoleK213241 · LON | bioMerieux, Inc. | 510(k) | Feb 25, 2022FDA decision date |
| API ID 32 C Strips, Reference 32200, Rx Only, IVD API ID 32 C is a qualitative standardized system for the identification of yeasts. It uses min…Z-0525-2022 · JXB | Biomerieux Inc | Recall | Jan 25, 2022FDA record creation date |
| VIDAS PRG Progesterone, REF 30409-01Z-0424-2022 · JLS | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS Clostridium Difficile Toxin A&B, CDAB,REF 30118-01Z-0425-2022 · LLH | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS Clostridium Difficile GDH, REF 30125-01Z-0426-2022 · MCB | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS DEX@, Dimer Exclusion II, REF 30455-01Z-0427-2022 · DAP | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS B.R.A.H.M.S. PROCALCITONIN PCT, REF 30450-01Z-0428-2022 · PRI | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS Mumps IgG (MPG), REF 30218Z-0429-2022 · LJY | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS Measles IgG (MSG), REF 30219Z-0430-2022 · LJB | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS TOXO IgG Avidity (TXGA), REF 30222-01Z-0431-2022 · LGD | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS RUB IgG (RBG), REF 30226Z-0432-2022 · LFX | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS LH, REF 30406-01Z-0433-2022 · CEP | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS FSH, REF 30407-01Z-0434-2022 · CGJ | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS Estradiol II, REF 30431-01Z-0435-2022 · CHP | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS Lyme IgM II (LYM), REF 416436Z-0436-2022 · LSR | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS Lyme IgG II (LYM), REF 417401Z-0437-2022 · LSR | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS SARS-COV-2 IgM, Ref 423833-01Z-0438-2022 · QKO | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| VIDAS SARS-COV-2 IgG, Ref 423834-01Z-0439-2022 · QKO | bioMerieux, Inc. | Recall | Dec 28, 2021FDA record creation date |
| RAPID 20 E, REF 20701, System for the identification of Enterobacteriaceae in 4 hours, 25 strips/package, IVD.Z-0422-2022 · JSS | Biomerieux Inc | Recall | Dec 27, 2021FDA record creation date |
| API 50 CH, Model 50300Z-0243-2022 · JSC | bioMerieux, Inc. | Recall | Nov 17, 2021FDA record creation date |
| VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL)K210287 · LON | bioMerieux, Inc. | 510(k) | Oct 28, 2021FDA decision date |
| VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL)K202396 · LON | bioMerieux, Inc. | 510(k) | Sep 14, 2021FDA decision date |
| VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL)K211630 · LON | bioMerieux, Inc. | 510(k) | Aug 30, 2021FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.